About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine landscape—Moderna has resolved a long-running patent feud. | Moderna will pay $950 ...
Federal Circuit affirms PTAB ruling against Implicit, holding late inventorship correction cannot revive patent arguments in ...
Moderna’s stock climbed in after-hours trading while shares of Arbutus fell.
Our Patent Case Summaries provide a weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or ...
After nearly five years of legal battles, the debate over the outcome of USAA's mobile check cashing patents with PNC Bank continues to heat up. The two banking ...
Nintendo's ongoing patent lawsuit case against Palworld developers Pocketpair has hit a surprising speedbump, though the battle is far from over. For those unaware, Nintendo is suing Pocketpair for ...
Arbutus Biopharma (ABUS) is a clinical-stage biotech focused on LNP technology, with value now hinging on ongoing patent litigation against Moderna and Pfizer/BioNTech. Recent management changes and ...
Nintendo’s ongoing legal campaign against Palworld developer Pocketpair has hit another roadblock. A key patent in Nintendo’s “monster capture” family, one that sits right between two patents, ...
“The CAFC said the district court found ‘the ’091 patent was ‘demonstrably weak on its face, despite the initial presumptions created when the patent was issued by the PTO.’” The U.S. Court of Appeals ...
Litigation finance involves investing money against legal or regulatory risk. [1] In a typical litigation finance investment, a funder deploys investment capital, and its return is determined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results